Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies

被引：14

作者：

Kuznetsova, Alla ^{[1
,2
]}

Popova, Olga ^{[1
]}

Panchenkov, Dmitry ^{[1
]}

Dyuzheva, Tatyana ^{[3
]}

Ivanov, Alexey ^{[1
]}

机构：

[1] AI Evdokimov Moscow State Univ Med & Dent, Minist Hlth Russian Federat, 20,Bld 1,Delegatskaya St, Moscow 127473, Russia

[2] Russian Acad Sci, Koltzov Inst Dev Biol, 26 Vavilov St, Moscow 119334, Russia

[3] IM Sechenov First Moscow State Med Univ, Sechenov Univ, Minist Hlth Russian Federat, 8-2 Trubetskaya St, Moscow 119991, Russia

来源：

CLINICAL AND EXPERIMENTAL MEDICINE | 2023年 / 23卷 / 03期

关键词：

Tumor microenvironment; Extracellular matrix; Cancer-associated fibroblasts; CAF heterogeneity; Pancreatic ductal adenocarcinoma; Stromal targeting; CARCINOMA-ASSOCIATED FIBROBLASTS; CANCER-ASSOCIATED FIBROBLASTS; PAPILLARY-MUCINOUS NEOPLASMS; FOCAL ADHESION KINASE; STELLATE CELLS; TGF-BETA; ANGIOTENSIN SYSTEM; GROWTH-FACTOR; SLIT-ROBO; RECEPTOR;

D O I：

10.1007/s10238-022-00886-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Diagnosis and treatment of carcinoma of the exocrine part of the pancreas is a serious problem for modern medicine. Despite the identification of a large number of aberrant mutations in pancreatic ductal adenocarcinoma (PDAC), attempts to create effective therapeutic agents based on identified genetic or epigenetic variations have not been succesful. The role of the tumor microenvironment (TME) in tumor progression is currently a popular topic. Cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM) are the main components of the tumor stroma and play an important role in the proliferation, invasiveness and metastasis of cancer. However, the mechanisms underlying the effect of CAFs and ECM on cancer progression are still unclear. Recent studies on stromal components and blockage of signaling pathways have brought some optimism to this area. New information on the role of TME will lead to the development of targeted therapies or combinations with modern chemotherapy for PDAC.

引用

页码：619 / 643

页数：25

共 150 条

[61] Hallmarks of Cancer: The Next Generation [J].

Hanahan, Douglas ;

Weinberg, Robert A. .

CELL, 2011, 144 (05) :646-674

[62] SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer [J].

Harris, N. L. E. ;

Vennin, C. ;

Conway, J. R. W. ;

Vine, K. L. ;

Pinese, M. ;

Cowley, M. J. ;

Shearer, R. F. ;

Lucas, M. C. ;

Herrmann, D. ;

Allam, A. H. ;

Pajic, M. ;

Morton, J. P. ;

Biankin, A. V. ;

Ranson, M. ;

Timpson, P. ;

Saunders, D. N. .

ONCOGENE, 2017, 36 (30) :4288-4298

[63] HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab- Paclitaxel/Gemcitabine Versus Nab- Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma [J].

Hingorani, Sunil R. ;

Zheng, Lei ;

Bullock, Andrea J. ;

Seery, Tara E. ;

Harris, William P. ;

Sigal, Darren S. ;

Braiteh, Fadi ;

Ritch, Paul S. ;

Zalupski, Mark M. ;

Bahary, Nathan ;

Oberstein, Paul E. ;

Wang-Gillam, Andrea ;

Wu, Wilson ;

Chondros, Dimitrios ;

Jiang, Ping ;

Khelifa, Sihem ;

Pu, Jie ;

Aldrich, Carrie ;

Hendifar, Andrew E. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) :359-+

[64] A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer [J].

Hochwald, Steven N. ;

Nyberg, Carl ;

Zheng, Min ;

Zheng, Donghang ;

Wood, Cheng ;

Massoll, Nicole A. ;

Magis, Andrew ;

Ostrov, David ;

Cance, William G. ;

Golubovskaya, Vita M. .

CELL CYCLE, 2009, 8 (15) :2435-2443

[65] Pancreatic cancer stroma: an update on therapeutic targeting strategies [J].

Hosein, Abdel N. ;

Brekken, Rolf A. ;

Maitra, Anirban .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (08) :487-505

[66] Ruxolitinib plus capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies [J].

Hurwitz, Herbert ;

Van Cutsem, Eric ;

Bendell, Johanna ;

Hidalgo, Manuel ;

Li, Chung-Pin ;

Garrido Salvo, Marcelo ;

Macarulla, Teresa ;

Sahai, Vaibhav ;

Sama, Ashwin ;

Greeno, Edward ;

Yu, Kenneth H. ;

Verslype, Chris ;

Dawkins, Fitzroy ;

Walker, Chris ;

Clark, Jason ;

O'Reilly, Eileen M. .

INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) :683-695

[67] Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics (Apr, 10.1038/s41388-022-02288-9, 2022) [J].

Iida, Tadashi ;

Mizutani, Yasuyuki ;

Esaki, Nobutoshi ;

Ponik, Suzanne M. ;

Burkel, Brian M. ;

Weng, Liang ;

Kuwata, Keiko ;

Masamune, Atsushi ;

Ishihara, Seiichiro ;

Haga, Hisashi ;

Kataoka, Kunio ;

Mii, Shinji ;

Shiraki, Yukihiro ;

Ishikawa, Takuya ;

Ohno, Eizaburo ;

Kawashima, Hiroki ;

Hirooka, Yoshiki ;

Fujishiro, Mitsuhiro ;

Takahashi, Masahide ;

Enomoto, Atsushi .

ONCOGENE, 2022, 41 (23) :3302-3302

[68] Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer [J].

Jacobetz, Michael A. ;

Chan, Derek S. ;

Neesse, Albrecht ;

Bapiro, Tashinga E. ;

Cook, Natalie ;

Frese, Kristopher K. ;

Feig, Christine ;

Nakagawa, Tomoaki ;

Caldwell, Meredith E. ;

Zecchini, Heather I. ;

Lolkema, Martijn P. ;

Jiang, Ping ;

Kultti, Anne ;

Thompson, Curtis B. ;

Maneval, Daniel C. ;

Jodrell, Duncan I. ;

Frost, Gregory I. ;

Shepard, H. M. ;

Skepper, Jeremy N. ;

Tuveson, David A. .

GUT, 2013, 62 (01) :112-U153

[69] Molecular regulation of pancreatic stellate cell function [J].

Jaster, Robert .

MOLECULAR CANCER, 2004, 3 (1)

[70] Cancer statistics, 2007 [J].

Jemal, Ahmedin ;

Siegel, Rebecca ;

Ward, Elizabeth ;

Murray, Taylor ;

Xu, Jiaquan ;

Thun, Michael J. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66

← 2 3 4 5 6 7 8 9 10 11 →